Clinical Research Directory
Browse clinical research sites, groups, and studies.
Red Light Treatment in Peripheral Artery Disease
Sponsor: University of Alabama at Birmingham
Summary
Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (\<.9 or \>1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above the gastrocnemius muscle. Blood flow will be measured by infusion of ultrasound contrast and subsequent acquisition of ultrasound images. 2 blood samples will be collected for measurement of nitric oxide metabolites.
Official title: Vasodilatory Effects of Light on Peripheral Artery Disease
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2018-01-17
Completion Date
2027-12-31
Last Updated
2025-04-01
Healthy Volunteers
No
Interventions
Red Light (670 nm energy)
Light Emitting Diode light source (670 nm wavelength with output up to 75mW/cm2) will be placed over the gastrocnemius muscle. The light will be on for 5 minutes.
Octafluoropropane
All subjects will undergo infusion of octafluoropropane to measure peripheral blood flow.
Locations (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, United States